 |
|
15th
World Congress Clinical Nutrition
19th
– 22nd September 2010 El Sokhna Resort - Egypt
|
 |
|
|
| |
 |
Copyright © 2010.
WCCN2010.COM All rights reserved |
|
 |
 |
Effects of MELISSA OFFICINALIS on
liver oxidant / antioxidant status
and serum glucose levels in
Streptozotocin – induced diabetic
rats
H Ozturk1, B. Ozturk2,
N. Sevinc1, I. Durak1
1Ankara University
Faculty of Medicine, Department of
Medical Biochemistry, Ankara,
Turkey.
2Selcuk University,
Selcuklu Medical Faculty, Department
of Biochemistry, Konya, Turkey.
|
Objective: Consumption of melissa officinalis (MO) as a
herbal tea has been traditionally
advised to diabetic patients in
Turkey for its anti-diabetic effect.
There are also some studies
reporting on the antioxidant content
and effects of this herb. In this
study, our aim was to establish the
effects of MO on serum glucose
levels and oxidant/antioxidant
status of liver tissue in
streptozotocin (STZ)-induced
diabetic rats.
Methods:
Twenty-five rats were included in
the study. In order to induce
diabetes, 60mg/kg STZ were
administered to 20 of the animals,
intraperitoneally. Eleven of the
STZ-treated rats were excluded from
the study (8 were died and 3 were
not diabetic). Groups were arranged
as; I-Controls (n=5), II-Diabetes
mellitus (n=4) and III-Diabetes
mellitus+melissae officinalis (n=5).
MO supplementation (200 mg/kg/day)
to diets of 5 hyperglycemic rats
were started 7 days after STZ
treatment and continued for 4 weeks.
Serum glucose and liver
malondialdehyde (MDA) levels and
activities of superoxide dismutase
(SOD), catalase (CAT), glutathione
peroxidase (GSH-Px) and xanthine
oxidase (XO) enzymes were measured.
Results: Serum
glucose level (454.637.5 vs.
547.034.8; p=0.022) and liver
tissue CAT (71.411.8 vs. 86.76.5)
and XO (0.260.05 vs. 0.330.10)
activities were found to be
increased in Group III compared to
Group II. There were no significant
differences with respect to liver
tissue MDA levels and GSH-Px
activities between all three groups.
Liver tissue SOD (142.5184 vs.
86.813.0 and 99.4±7.7) and XO
(0.540.07 vs. 0.260.05 and
0.33±0.10) activities were found to
be decreased in both diabetes groups
(Groups II and III) compared to
controls (Group I).
Conclusions: In
this study, MO did not exert any
antidiabetic effect. MDA levels
pointed out that induction of
diabetes via STZ treatment does not
have any oxidative effect on liver
tissue, also. On the other hand, STZ
treatment lowered both SOD and XO
enzyme levels.
|
|
| |
|
 |
|
:: :: :: :: |
|